Meghan Fitzgerald
CIK 1349297 · EVP, Strategy & Health Policy · last filed 2026-05-28
Meghan Fitzgerald is an EVP, Strategy & Health Policy who has filed 32 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for THC, was dated May 28, 2026. Across all open-market trades the lifetime net is −$5.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$10.13M
6
32
-$5.60M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| THC | Director | 17,087 | $174.66 | $2.98M | -$3.68M | 15 | 2026-05-28 |
| ROIV | Director | 112,963 | $30.04 | $3.39M | -$1.92M | 8 | 2026-03-30 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Director | 1,152 | $2.75 | $3.2K | $0 | 2 | 2023-07-06 |
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Director | — | $8.37 | — | $0 | 3 | 2018-06-18 |
| CAH | EVP, Strategy & Health Policy | 16,760 | $223.85 | $3.75M | $0 | 3 | 2015-11-17 |
| VION PHARMACEUTICALS INC (VION) Delisted | VP and Chief Business Officer | 555,000 | — | — | $0 | 1 | 2007-03-14 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-28 | THC | Grant (A) | — | $0 | EDGAR |
| 2026-05-26 | THC | Mixed | +840 | -$85.7K | EDGAR |
| 2026-03-30 | ROIV | Mixed | — | -$1.31M | EDGAR |
| 2025-09-12 | ROIV | Mixed | +13,587 | -$12.9K | EDGAR |
| 2025-05-27 | THC | Mixed | +978 | -$92.4K | EDGAR |
| 2024-09-16 | ROIV | Other (J) | −894 | -$10.8K | EDGAR |
| 2024-09-12 | ROIV | Grant (A) | +16,406 | $0 | EDGAR |
| 2024-08-08 | THC | Sell (S) | −20,000 | -$2.93M | EDGAR |
| 2024-05-28 | THC | Grant (A) | — | $0 | EDGAR |
| 2024-04-26 | ROIV | Mixed | +1,178 | -$905 | EDGAR |